{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T17:12:59Z","timestamp":1791825179483,"version":"4.3.4"},"reference-count":115,"publisher":"Informa UK Limited","issue":"5","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Neurotherapeutics"],"published-print":{"date-parts":[[2022,5,4]]},"DOI":"10.1080\/14737175.2022.2060742","type":"journal-article","created":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T05:12:15Z","timestamp":1648703535000},"page":"365-376","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":9,"title":["Olanzapine-samidorphan combination tablets for the treatment of schizophrenia and bipolar I disorder - what is it, and will it be used?"],"prefix":"10.1080","volume":"22","author":[{"given":"Justin","family":"Faden","sequence":"first","affiliation":[{"name":"Department of Psychiatry, Lewis Katz School of Medicine at Temple University, Philadelphia, PA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Serdenes","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Lewis Katz School of Medicine at Temple University, Philadelphia, PA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie","family":"Citrome","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, New York Medical College, Valhalla, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2022,4,13]]},"reference":[{"key":"cit0001","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2015.67"},{"key":"cit0002","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sby058"},{"key":"cit0003","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61729-2"},{"key":"cit0004","doi-asserted-by":"publisher","DOI":"10.1002\/wps.20516"},{"key":"cit0005","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1911772"},{"key":"cit0006","doi-asserted-by":"publisher","DOI":"10.1016\/j.scog.2021.100217"},{"key":"cit0007","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2021.11.010"},{"key":"cit0008","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)60733-3"},{"key":"cit0009","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)31135-3"},{"key":"cit0010","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2018.1543409"},{"key":"cit0011","doi-asserted-by":"publisher","DOI":"10.3371\/1935-1232.10.3.163"},{"key":"cit0012","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)61764-X"},{"key":"cit0013","doi-asserted-by":"publisher","DOI":"10.1002\/wps.20632"},{"key":"cit0014","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S209284"},{"issue":"3","key":"cit0015","volume":"17","author":"Komossa K","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"cit0016","doi-asserted-by":"publisher","DOI":"10.1186\/1471-244X-8-31"},{"key":"cit0017","doi-asserted-by":"publisher","DOI":"10.2147\/POR.S64973"},{"key":"cit0018","doi-asserted-by":"publisher","DOI":"10.1586\/ern.09.54"},{"key":"cit0019","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2016.3803"},{"key":"cit0020","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(19)30416-X"},{"key":"cit0021","doi-asserted-by":"publisher","DOI":"10.1172\/JCI93362"},{"key":"cit0022","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbp116"},{"key":"cit0023","doi-asserted-by":"publisher","DOI":"10.1177\/0004867416641195"},{"key":"cit0024","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-013881"},{"key":"cit0025","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(17)30270-5"},{"key":"cit0026","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2017.06.011"},{"key":"cit0027","volume-title":"Agency for healthcare research and quality","author":"McDonagh MS","year":"2017"},{"key":"cit0028","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)60486-9"},{"key":"cit0029","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa051688"},{"key":"cit0030","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.63.10.1079"},{"key":"cit0031","volume-title":"Lybalvi [package insert]","year":"2021"},{"key":"cit0032","doi-asserted-by":"publisher","DOI":"10.12788\/cp.0203"},{"key":"cit0033","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-443-06651-1.50014-9"},{"key":"cit0034","doi-asserted-by":"publisher","DOI":"10.1093\/bjaceaccp\/mku041"},{"key":"cit0035","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.104938"},{"key":"cit0036","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.5b01499"},{"key":"cit0037","doi-asserted-by":"publisher","DOI":"10.1038\/s41386-018-0225-3"},{"key":"cit0038","doi-asserted-by":"publisher","DOI":"10.1177\/0269881119856850"},{"key":"cit0039","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2012.01.013"},{"issue":"4","key":"cit0040","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1002\/cncr.20024","volume":"100","author":"Mauck WD","year":"2004","journal-title":"Cancer"},{"key":"cit0041","doi-asserted-by":"publisher","DOI":"10.1177\/0963689718811060"},{"key":"cit0042","doi-asserted-by":"publisher","DOI":"10.1016\/j.peptides.2004.01.006"},{"key":"cit0043","doi-asserted-by":"publisher","DOI":"10.1016\/j.peptides.2015.03.019"},{"key":"cit0044","doi-asserted-by":"publisher","DOI":"10.1159\/000338163"},{"key":"cit0045","doi-asserted-by":"publisher","DOI":"10.1017\/9781108975292"},{"key":"cit0046","doi-asserted-by":"publisher","DOI":"10.1152\/ajpregu.00271.2003"},{"key":"cit0047","doi-asserted-by":"publisher","DOI":"10.1210\/endo.143.8.8977"},{"key":"cit0048","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2013.28"},{"key":"cit0049","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2008.05.040"},{"key":"cit0050","first-page":"2138","volume":"83","author":"Wand GS","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"cit0051","doi-asserted-by":"publisher","DOI":"10.1038\/s41366-021-00996-y"},{"key":"cit0052","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2005.02.032"},{"key":"cit0053","unstructured":"Alkermes (2006 Oct 6th). Press release: alkermes and rensselaer polytechnic institute announce exclusive licensing agreement for novel opioid receptor compounds. https:\/\/investor.alkermes.com\/news-releases\/news-release-details\/alkermes-and-rensselaer-polytechnic-institute-announce-exclusive"},{"key":"cit0054","unstructured":"Alkermes (2008,December 4th). Alkermes Initiates Clinical Trial for ALKS 33, a Novel Oral Molecule with Potential Benefits in Addiction and Other CNS Disorders. https:\/\/pipelinereview.com\/index.php\/2008120423797\/Small-Molecules\/Alkermes-Initiates-Clinical-Trial-for-ALKS-33-a-Novel-Oral-Molecule-with-Potential-Benefits-in-Addiction-and-Other-CNS-Disorders.html"},{"key":"cit0055","unstructured":"Alkermes (2009 Nov 17th). Alkermes Initiates Phase 2 Clinical Study of ALKS 33 for the Treatment of Alcohol Dependence. https:\/\/investor.alkermes.com\/news-releases\/news-release-details\/alkermes-initiates-phase-2-clinical-study-alks-33-treatment"},{"key":"cit0056","unstructured":"Alkermes (2010 Oct 25th). Alkermes Announces Positive Results from Phase 1 Study of ALKS 33 in Combination with Buprenorphine for Treatment of Cocaine Addiction. URL: https:\/\/investor.alkermes.com\/news-releases\/news-release-details\/alkermes-announces-positive-results-phase-1-study-alks-33"},{"key":"cit0057","unstructured":"Alkermes (2011 Jul 7th) Alkermes Announces Results from Phase 2 Study of ALKS 33 for Treatment of Binge Eating Disorder. https:\/\/investor.alkermes.com\/news-releases\/news-release-details\/alkermes-announces-results-phase-2-study-alks-33-treatment-binge"},{"key":"cit0058","unstructured":"Alkermes (2014 Jul 30th). Alkermes Announces Initiation of FORWARD-5 Clinical Study of ALKS 5461 For Treatment of Major Depressive Disorder. https:\/\/investor.alkermes.com\/news-releases\/news-release-details\/alkermes-announces-initiation-forward-5-clinical-study-alks-5461"},{"key":"cit0059","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2020.03.089"},{"key":"cit0060","unstructured":"Alkermes. (2019 Feb 1st). Alkermes Receives Complete Response Letter From U.S. Food and Drug Administration for ALKS 5461 New Drug Application. URL: https:\/\/investor.alkermes.com\/news-releases\/news-release-details\/alkermes-receives-complete-response-letter-us-food-and-drug"},{"key":"cit0061","unstructured":"Alkermes (2013 Jan 3rd). Alkermes expands CNS pipeline and announces positive results from phase 1 Study of ALKS 3831, a novel antipsychotic therapy for the treatment of schizophrenia. URL: https:\/\/investor.alkermes.com\/news-releases\/news-release-details\/alkermes-expands-cns-pipeline-and-announces-positive-results"},{"key":"cit0062","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S313840"},{"key":"cit0063","unstructured":"Alkermes (2021 Jun 1st). Alkermes announces FDA approval of LYBALVI\u2122 for the treatment of schizophrenia and bipolar i disorder. https:\/\/investor.alkermes.com\/news-releases\/news-release-details\/alkermes-announces-fda-approval-lybalvitm-treatment"},{"key":"cit0064","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-420118-7.10000-9"},{"key":"cit0065","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2021.02.954"},{"key":"cit0066","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2019.05.012"},{"key":"cit0067","doi-asserted-by":"publisher","DOI":"10.1007\/s40268-019-00280-5"},{"key":"cit0068","doi-asserted-by":"publisher","DOI":"10.1002\/cpdd.688"},{"key":"cit0069","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2018.09.002"},{"key":"cit0070","doi-asserted-by":"publisher","DOI":"10.1007\/s40261-019-00860-y"},{"key":"cit0071","doi-asserted-by":"publisher","DOI":"10.1002\/psp4.12675"},{"key":"cit0072","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.19m12769"},{"key":"cit0073","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/13.2.261"},{"key":"cit0074","first-page":"76","volume-title":"Rockville, md: u.s. dept. of health, education, and welfare, public health service, alcohol, drug abuse, and mental health administration, national institute of mental health, psychopharmacology research branch, division of extramural research programs","author":"Guy W","year":"1976"},{"key":"cit0075","doi-asserted-by":"publisher","DOI":"10.1017\/S1092852920001376"},{"key":"cit0076","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2020.19121279"},{"key":"cit0077","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2021.04.009"},{"key":"cit0078","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2018.18030280"},{"key":"cit0079","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.19m12786"},{"key":"cit0080","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2020.109881"},{"key":"cit0081","doi-asserted-by":"publisher","DOI":"10.1176\/ps.2008.59.5.500"},{"key":"cit0082","volume-title":"Olanzapine [package insert]","year":"2021"},{"key":"cit0083","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e3181a289cb"},{"key":"cit0084","unstructured":"GoodRx, Inc. Olanzapine, https:\/\/www.goodrx.com\/olanzapine (accessed 2021 Nov 23)."},{"key":"cit0085","unstructured":"GoodRx, Inc. Lybalvi, https:\/\/www.goodrx.com\/lybalvi (accessed 2021 Nov 23)."},{"key":"cit0086","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.2006.163.4.600"},{"key":"cit0087","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2015.2955"},{"key":"cit0088","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2006.09.005"},{"key":"cit0089","doi-asserted-by":"publisher","DOI":"10.1002\/wps.20384"},{"key":"cit0090","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2013.11.011"},{"key":"cit0091","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/85.5.1197"},{"key":"cit0092","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000000523"},{"key":"cit0093","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S113099"},{"key":"cit0094","doi-asserted-by":"publisher","DOI":"10.1177\/0269881116645254"},{"key":"cit0095","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.107.042853"},{"key":"cit0096","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0112276"},{"key":"cit0097","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbaa191"},{"key":"cit0098","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.577919"},{"key":"cit0099","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e31817e63a5"},{"key":"cit0100","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2011.10111609"},{"key":"cit0101","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0244944"},{"key":"cit0102","doi-asserted-by":"publisher","DOI":"10.1002\/j.1550-8528.1998.tb00314.x"},{"key":"cit0103","doi-asserted-by":"publisher","DOI":"10.1172\/JCI13505"},{"key":"cit0104","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-016-1049-5"},{"key":"cit0105","doi-asserted-by":"publisher","DOI":"10.1002\/wps.20714"},{"key":"cit0106","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000000192"},{"key":"cit0107","doi-asserted-by":"publisher","DOI":"10.1111\/acps.13266"},{"key":"cit0108","doi-asserted-by":"publisher","DOI":"10.1080\/13651501.2018.1449864"},{"key":"cit0109","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e31827cb2b7"},{"key":"cit0110","volume-title":"Topiramate [package insert]","year":"2021"},{"key":"cit0111","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000001470"},{"key":"cit0112","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000001481"},{"key":"cit0113","doi-asserted-by":"publisher","DOI":"10.1177\/0269881112473789"},{"key":"cit0114","doi-asserted-by":"publisher","DOI":"10.1055\/s-0030-1248313"},{"key":"cit0115","first-page":"1","volume":"3","author":"McIntyre RS","year":"2022","journal-title":"CNS Spectr"}],"container-title":["Expert Review of Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14737175.2022.2060742","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,18]],"date-time":"2022-05-18T18:26:12Z","timestamp":1652898372000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14737175.2022.2060742"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,13]]},"references-count":115,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5,4]]}},"alternative-id":["10.1080\/14737175.2022.2060742"],"URL":"https:\/\/doi.org\/10.1080\/14737175.2022.2060742","relation":{},"ISSN":["1473-7175","1744-8360"],"issn-type":[{"value":"1473-7175","type":"print"},{"value":"1744-8360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,13]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iern20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iern20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2022-01-31","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-03-29","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-04-13","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}